Vectura Group (VEC)

 

VEC Share PerformanceMore

52 week high166.95 21/03/17
52 week low107.60 22/08/17
52 week change -28.80 (-20.48%)
4 week volume22,718,371 28/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hikma statement on generic Advair Diskus? (VR315)

RNS Number: 2460O Vectura Group plc 17 August 2017 Vectura Group plc Hikma Interim Results statement on its ANDA for generic Advair Diskus (VR315) Chippenham, UK - 17 August 2017: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading device and formulation business for inhaled airways products, today confirms the statement made by its par...

Vectura signs exclusive agreement with Dynavax

Inhaled airways products specialist Vectura has signed an exclusive global agreement with Dynavax Technologies for the c...

Global development agreement with Dynavax

RNS Number: 0976O Vectura Group plc 16 August 2017 Vectura Group plc Global development agreement with Dynavax for lung cancer programme using Vectura's smart nebuliser technology (VR347) Chippenham, UK - 16 August 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation business for inhaled airw...

Director Deals - Vectura Group PLC (VEC)

Andrew Derodra, Financial Director, bought 135 shares in the company on the 4th August 2017 at a price of 111.30p. The Dir...

Director/PDMR Shareholding

RNS Number: 3035N Vectura Group plc 07 August 2017 VECTURA GROUP PLC DIRECTOR/PDMR SHARE DEALING Vectura Group plc 7 August 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them Vectura Group plc (LSE: VEC; "Vectura" or "the Company") confi...

Voting Rights and Capital

RNS Number: 7629M Vectura Group plc 01 August 2017 VECTURA GROUP PLC (the "Company") VOTING RIGHTS AND CAPITAL 1 August 2017 Vectura Group plc (LSE: VEC) notifies that the Company's issued share capital as at 31 July 2017 consisted of 679,343,752 ordinary shares (previously 679,343,752. ordinary shares as at 30 June 2017) and 34,000 preference...

Notice of Interim Results

RNS Number: 2146M Vectura Group plc 27 July 2017 Vectura Group plc Notice of Interim Results Chippenham, UK, 27 July 2017: Vectura Group plc (LSE: VEC) ("the Group"), an industry-leading inhaled airways disease focused business, plans to announce its Interim Results for the six-month period ending 30 June 2017 on Wednesday 6 September 2017. James War...

Director Deals - Vectura Group PLC (VEC)

Andrew Derodra, Financial Director, bought 132 shares in the company on the 6th July 2017 at a price of 113.60p. The Direc...

Fundamental DataMore

P/E ratio93.167
EPS1.2
Dividend yield0 %

Latest discussion posts More

  • Re: Shire

    Up the stairs and down the escalator! I usually prefer shorting....not that I am with VEC.
    21-Aug-2017
    IAmShareCrazy
  • Re: Shire

    I am definitely clutching at straws & due to my exposure here looking at any options to encourage me.Sadly brokers forecasts of 150p & 160p are not yet helping sentiment & I am ...
    21-Aug-2017
    dave297
  • Re: Shire

    Up the stairs and down the escalator! I usually prefer shorting....not that I am with VEC.
    21-Aug-2017
    IAmShareCrazy

Users' HoldingsMore

Users who hold Vectura Group also hold..
LLOYDS GRP.32%
VODAFONE GRP.23%
BP21%
BARCLAYS16%
TESCO16%

Codes & Symbols

ISINGB00B01D1K48
SymbolsVEC, LSE:VEC, VEC.L, VEC:LN, LON:VEC, XLON:VEC